Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Top Cited Papers
Open Access
Abstract
Oral mucositis is a complication of intensive chemotherapy and radiotherapy with no effective treatment. We tested the ability of palifermin (recombinant human keratinocyte growth factor) to decrease oral mucosal injury induced by cytotoxic therapy.

This publication has 26 references indexed in Scilit: